insights

The New Era of Alzheimer’s Treatment with Dale Bredesen, MD

Dale Bredesen, MD

Alzheimer’s disease is now the third leading cause of death in the US,1 and in the UK, dementia is actually the number one cause of death.2 It is claimed that “no one survives a diagnosis of dementia,” a disease with “no effective treatment.” As practitioners, we have struggled over the years with patients with cognitive decline, since there has been so little to offer.

Over the past 28 years, my laboratory colleagues and I have studied the molecular mechanisms that underlie Alzheimer’s disease, published over 200 papers on this topic, and finally, in 20143 and 2016,4 reported the first examples of the reversal of cognitive decline in Alzheimer’s disease and pre-Alzheimer’s (MCI and SCI). These personalized protocols are now in use by over 1,000 people.

We have received thousands of emails asking for more specifics and more background, so I provided these in a book, The End of Alzheimer’s, from Avery/Penguin Random House.

The End of Alzheimer's Book by Dale Bredesen, MD
Download a free sample chapter here .

The fundamental mechanistic studies we performed over the past three decades led us directly to a Functional Medicine approach to cognitive decline, and IFM formerly offered an online course on Reversing Cognitive Decline.

This is a very exciting time, a truly revolutionary era—Functional Medicine is effecting unprecedented success in the treatment of complex chronic illnesses, from type 2 diabetes to lupus to rheumatoid arthritis to cardiovascular disease to Alzheimer’s disease. Working together as a medical community, and continuing to optimize our approach to the prevention and reversal of cognitive decline, we can slash the global burden of dementia. That would truly be a revolution to celebrate.

Explore Ways to Help Patients with Cognitive Decline

References

  1. James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014;82(12):1045-1050. doi:10.1212/WNL.0000000000000240.
  2. Statistical bulletin: deaths registered in England and Wales (Series DR): 2015. Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredinenglandandwalesseriesdr/2015#dementia-and-alzheimer-disease-was-the-leading-cause-of-death-in-2015. Published November 14, 2016. Accessed August 21, 2017.
  3. Bredesen DE. Reversal of cognitive decline: a novel therapeutic program. Aging (Albany NY). 2014;6(9):707-717. doi:10.18632/aging.100690.
  4. Bredesen DE. Inhalational Alzheimer’s disease: an unrecognized—and treatable—epidemic. Aging (Albany NY). 2016;8(2):304-313. doi:10.18632/aging.100896.

< Back to News & Insights

Related Insights

Insights
Group 2

Neurodegenerative Disease: Improving Outcomes Through Nutrition

Neuroinflammation, oxidative stress, and mitochondrial dysfunction have all been noted in the progression of neurodegenerative diseases. Nutrition strategies that include nutrient-based antioxidants and anti-inflammatory agents as well as therapeutic food plans that support mitochondrial function and brain health may improve patient outcomes.

Read More
Insights
Group 2

Sleep and Biotransformation

Americans are getting less sleep, with many health consequences. Declining brain health may be one result.

Read More

Linus Pauling Award Winner Interview: Drs. Bland and Wahls

For 2018 Linus Pauling Award Winner Terry Wahls, MD, reversing the loss of function from multiple sclerosis is personal. Dr. Wahls pioneered a food and lifestyle intervention that is proving enormously beneficial to many multiple sclerosis patients, including restoring her own physical and mental function.

Read More